Cargando…

Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer

BACKGROUND: Lung cancer has become one of the deadliest tumors in the world. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 80%-85% of all lung cancer cases. This study aimed to investigate the value of diffusion kurtosis imaging (DKI), diffus...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Pengyang, Shao, Zehua, Dong, Bai, Fang, Ting, Huang, Zhun, Li, Ziqiang, Fu, Fangfang, Wu, Yaping, Wei, Wei, Yuan, Jianmin, Yang, Yang, Wang, Zhe, Wang, Meiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562703/
https://www.ncbi.nlm.nih.gov/pubmed/36248958
http://dx.doi.org/10.3389/fonc.2022.989131
_version_ 1784808233393717248
author Feng, Pengyang
Shao, Zehua
Dong, Bai
Fang, Ting
Huang, Zhun
Li, Ziqiang
Fu, Fangfang
Wu, Yaping
Wei, Wei
Yuan, Jianmin
Yang, Yang
Wang, Zhe
Wang, Meiyun
author_facet Feng, Pengyang
Shao, Zehua
Dong, Bai
Fang, Ting
Huang, Zhun
Li, Ziqiang
Fu, Fangfang
Wu, Yaping
Wei, Wei
Yuan, Jianmin
Yang, Yang
Wang, Zhe
Wang, Meiyun
author_sort Feng, Pengyang
collection PubMed
description BACKGROUND: Lung cancer has become one of the deadliest tumors in the world. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 80%-85% of all lung cancer cases. This study aimed to investigate the value of diffusion kurtosis imaging (DKI), diffusion-weighted imaging (DWI) and 2-[(18)F]-fluoro-2-deoxy-D-glucose positron emission tomography ((18)F-FDG PET) in differentiating squamous cell carcinoma (SCC) and adenocarcinoma (AC) and to evaluate the correlation of each parameter with stage and proliferative status Ki-67. METHODS: Seventy-seven patients with lung lesions were prospectively scanned by hybrid 3.0-T chest (18)F-FDG PET/MR. Mean kurtosis (MK), mean diffusivity (MD), apparent diffusion coefficient (ADC), maximum standard uptake value (SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured. The independent samples t test or Mann–Whitney U test was used to compare and analyze the differences in each parameter of SCC and AC. The diagnostic efficacy was evaluated by receiver operating characteristic (ROC) curve analysis and compared with the DeLong test. A logistic regression analysis was used for the evaluation of independent predictors. Bootstrapping (1000 samples) was performed to establish a control model, and calibration curves and ROC curves were used to validate its performance. Pearson’s correlation coefficient and Spearman’s correlation coefficient were calculated for correlation analysis. RESULTS: The MK and ADC values of the AC group were significantly higher than those of the SCC group (all P< 0.05), and the SUVmax, MTV, and TLG values of the SCC group were significantly higher than those of the AC group (all P<0.05). There was no significant difference in the MD value between the two groups. Moreover, MK, SUVmax, TLG and MTV were independent predictors of the NSCLC subtype, and the combination of these parameters had an optimal diagnostic efficacy (AUC, 0.876; sensitivity, 86.27%; specificity, 80.77%), which was significantly better than that of MK (AUC = 0.758, z = 2.554, P = 0.011), ADC (AUC = 0.679, z = 2.322, P = 0.020), SUVmax (AUC = 0.740, z = 2.584, P = 0.010), MTV (AUC = 0.715, z = 2.530, P = 0.011) or TLG (AUC = 0.716, z = 2.799, P = 0.005). The ROC curve showed that the validation model had high accuracy in identifying AC and SCC (AUC, 0.844; 95% CI, 0.785-0.885);. The SUVmax value was weakly positively correlated with the Ki-67 index (r = 0.340, P< 0.05), the ADC and MD values were weakly negatively correlated with the Ki-67 index (r = -0.256, -0.282, P< 0.05), and the MTV and TLG values were weakly positively correlated with NSCLC stage (r = 0.342, 0.337, P< 0.05). CONCLUSION: DKI, DWI and (18)F-FDG PET are all effective methods for assessing the NSCLC subtype, and some parameters are correlated with stage and proliferation status.
format Online
Article
Text
id pubmed-9562703
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95627032022-10-15 Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer Feng, Pengyang Shao, Zehua Dong, Bai Fang, Ting Huang, Zhun Li, Ziqiang Fu, Fangfang Wu, Yaping Wei, Wei Yuan, Jianmin Yang, Yang Wang, Zhe Wang, Meiyun Front Oncol Oncology BACKGROUND: Lung cancer has become one of the deadliest tumors in the world. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 80%-85% of all lung cancer cases. This study aimed to investigate the value of diffusion kurtosis imaging (DKI), diffusion-weighted imaging (DWI) and 2-[(18)F]-fluoro-2-deoxy-D-glucose positron emission tomography ((18)F-FDG PET) in differentiating squamous cell carcinoma (SCC) and adenocarcinoma (AC) and to evaluate the correlation of each parameter with stage and proliferative status Ki-67. METHODS: Seventy-seven patients with lung lesions were prospectively scanned by hybrid 3.0-T chest (18)F-FDG PET/MR. Mean kurtosis (MK), mean diffusivity (MD), apparent diffusion coefficient (ADC), maximum standard uptake value (SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were measured. The independent samples t test or Mann–Whitney U test was used to compare and analyze the differences in each parameter of SCC and AC. The diagnostic efficacy was evaluated by receiver operating characteristic (ROC) curve analysis and compared with the DeLong test. A logistic regression analysis was used for the evaluation of independent predictors. Bootstrapping (1000 samples) was performed to establish a control model, and calibration curves and ROC curves were used to validate its performance. Pearson’s correlation coefficient and Spearman’s correlation coefficient were calculated for correlation analysis. RESULTS: The MK and ADC values of the AC group were significantly higher than those of the SCC group (all P< 0.05), and the SUVmax, MTV, and TLG values of the SCC group were significantly higher than those of the AC group (all P<0.05). There was no significant difference in the MD value between the two groups. Moreover, MK, SUVmax, TLG and MTV were independent predictors of the NSCLC subtype, and the combination of these parameters had an optimal diagnostic efficacy (AUC, 0.876; sensitivity, 86.27%; specificity, 80.77%), which was significantly better than that of MK (AUC = 0.758, z = 2.554, P = 0.011), ADC (AUC = 0.679, z = 2.322, P = 0.020), SUVmax (AUC = 0.740, z = 2.584, P = 0.010), MTV (AUC = 0.715, z = 2.530, P = 0.011) or TLG (AUC = 0.716, z = 2.799, P = 0.005). The ROC curve showed that the validation model had high accuracy in identifying AC and SCC (AUC, 0.844; 95% CI, 0.785-0.885);. The SUVmax value was weakly positively correlated with the Ki-67 index (r = 0.340, P< 0.05), the ADC and MD values were weakly negatively correlated with the Ki-67 index (r = -0.256, -0.282, P< 0.05), and the MTV and TLG values were weakly positively correlated with NSCLC stage (r = 0.342, 0.337, P< 0.05). CONCLUSION: DKI, DWI and (18)F-FDG PET are all effective methods for assessing the NSCLC subtype, and some parameters are correlated with stage and proliferation status. Frontiers Media S.A. 2022-09-30 /pmc/articles/PMC9562703/ /pubmed/36248958 http://dx.doi.org/10.3389/fonc.2022.989131 Text en Copyright © 2022 Feng, Shao, Dong, Fang, Huang, Li, Fu, Wu, Wei, Yuan, Yang, Wang and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Feng, Pengyang
Shao, Zehua
Dong, Bai
Fang, Ting
Huang, Zhun
Li, Ziqiang
Fu, Fangfang
Wu, Yaping
Wei, Wei
Yuan, Jianmin
Yang, Yang
Wang, Zhe
Wang, Meiyun
Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
title Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
title_full Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
title_fullStr Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
title_full_unstemmed Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
title_short Application of diffusion kurtosis imaging and (18)F-FDG PET in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
title_sort application of diffusion kurtosis imaging and (18)f-fdg pet in evaluating the subtype, stage and proliferation status of non-small cell lung cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562703/
https://www.ncbi.nlm.nih.gov/pubmed/36248958
http://dx.doi.org/10.3389/fonc.2022.989131
work_keys_str_mv AT fengpengyang applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT shaozehua applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT dongbai applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT fangting applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT huangzhun applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT liziqiang applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT fufangfang applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT wuyaping applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT weiwei applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT yuanjianmin applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT yangyang applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT wangzhe applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer
AT wangmeiyun applicationofdiffusionkurtosisimagingand18ffdgpetinevaluatingthesubtypestageandproliferationstatusofnonsmallcelllungcancer